A similar distribution was achieved for MGMT promotor (methylated in 53%), recurrent surgery (19%) and categorical distribution of eloquent location (eloquent in 45%) and tumor size (>40cc in 39% of cases). This evidence concerns the gene MGMT and neoplasm.